CTL quality and the control of human retroviral infections.
about
Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 ProvirusMultifaceted functions and roles of HBZ in HTLV-1 pathogenesisFrom Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 LeukemogenesisHow does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?T-cell Receptor-optimized Peptide Skewing of the T-cell Repertoire Can Enhance Antigen TargetingHTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infectionCharacterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection.HIV Infection and Gut Mucosal Immune Function: Updates on Pathogenesis with Implications for Management and Intervention.HLA class I binding of HBZ determines outcome in HTLV-1 infection.Identification and characterization of HLA-A*0301 epitopes in HIV-1 gag proteins using a novel approachHIV-1 neuroimmunity in the era of antiretroviral therapy.The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma.TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)Dendritic cells restore CD8+ T cell reactivity to autologous HIV-1Molecular characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159).HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infectionStrongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivoThe host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clonesIn vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome.Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection.Clonality of HTLV-2 in natural infection.TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax.High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV controlVaccinomics and a new paradigm for the development of preventive vaccines against viral infections.Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.Tight regulation of memory CD8(+) T cells limits their effectiveness during sustained high viral loadHigh prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease.Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells.Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infectionHuman T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells.HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs.Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications.Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.The 14th International Conference on Human Retrovirology: HTLV and related retroviruses (July 1-4, 2009; Salvador, Brazil)A real-time killing assay to follow viral epitope presentation to CD8 T cellsDirect microbicidal activity of cytotoxic T-lymphocytes.
P2860
Q26744327-5CEB365E-0970-48AA-9861-6A6992655D00Q26765424-129005EB-CB2C-4E45-8948-72CFCFFA9282Q26774369-8AAE041D-75D5-43C4-8E13-80823ECF9BFEQ26785554-F1B20B57-A995-4E96-B38B-7E1690DF4056Q27672418-1ADD9CF6-C7D2-4453-B319-485AC124CD57Q31151159-CB37840B-2311-4CA7-936D-1B2F6B96E21BQ33590318-8A4EBE6E-46B6-4A96-9FB5-308D8CA7EB26Q33651723-DBA474FE-909F-439A-A6D3-73C31213CC0CQ33707746-86445338-0CB1-4F5F-BCE5-FE14CB2C2475Q33717999-AC093A8F-E960-4078-A57C-AC2ADA8C6907Q33733529-5D262D5A-E6BD-4EB1-97E7-7760F87837E6Q33781166-8F9E9576-AF3C-4C7B-BD0F-AD8BEBC610BFQ33939303-B2629C2E-37F4-4D9A-BBC8-F8EB8E7CDDCBQ34059416-1C88364E-6420-4BEF-AA31-662F24A74A87Q34062308-F6E3601E-C2D3-40D9-93A5-30171E50AA99Q34316662-C292DCC9-88B2-4DC3-8AB6-2146E7285844Q34649734-27C0A1C3-D781-4920-AD54-A3CACF1F0578Q34671871-E221FBF8-7010-4CD9-A9A4-BCC42D00661FQ34707243-6C49DD8D-A493-429B-BE74-4B23D3B6B3B0Q34764429-59BB7578-2DF1-4DCB-BDE5-42D5E96A51D8Q35008829-E2386235-1430-4B47-AFD4-1F2DE0F81BE3Q35120139-2397027C-A274-4A53-BB81-5E143151577EQ35128946-91DDD95E-9CB0-4025-8F4C-E08A5D94B288Q35192655-2A6B1E4C-5F00-4D39-B041-B097F01B6996Q35193959-B73AFF53-E0E6-49A5-A1F4-5D0EFDB6238BQ35261463-90FBC723-3631-4B0D-921C-DB8D1BE4F801Q35621976-90B503F4-57A6-47CB-B005-2DB22BCF12DDQ35682787-9947E40B-F5B7-4425-AADC-FDADB1598255Q35806714-1FCDC573-3DAD-46B2-8915-E21109CFB1C0Q35864285-C8DA4728-0985-427C-806E-9F7AC00F9969Q36277748-03093917-0ABF-4B9C-B26C-BCB4EF8B469DQ36617341-7BDD9504-DFEC-42CA-ADFE-6C30A6C104F3Q36770954-1882ABE5-8D02-452D-96EC-9074D4D315C7Q37069833-DB6D0744-D026-4558-8D1D-9B49DD7178F9Q37153763-2A26AE3D-F4A0-44F2-BDF8-6804C922BBFAQ37194029-BFA59482-DA99-48E0-883F-4124B8055C47Q37200968-BD9E87E5-9D2D-413C-B990-555D66D5C6F2Q37325424-2310077A-EC06-4093-BC17-FA92036DE6FFQ37352748-12179115-4BAA-49EF-A6AE-7A9744839CB1Q37771265-FC9D2E4B-FF46-49F3-8B16-7CB772000E4B
P2860
CTL quality and the control of human retroviral infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CTL quality and the control of human retroviral infections.
@en
CTL quality and the control of human retroviral infections.
@nl
type
label
CTL quality and the control of human retroviral infections.
@en
CTL quality and the control of human retroviral infections.
@nl
prefLabel
CTL quality and the control of human retroviral infections.
@en
CTL quality and the control of human retroviral infections.
@nl
P2860
P356
P1476
CTL quality and the control of human retroviral infections.
@en
P2093
Charles R M Bangham
P2860
P304
P356
10.1002/EJI.200939451
P407
P577
2009-07-01T00:00:00Z